a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem. Pharmacol., 65, 2065–2071, 2003.
60. Gursoy, R.N. and Benita, S., Self-emulsifying drug delivery systems (SMEDDs) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother., 58, 173–182, 2004.
61. Constantinides, P.P., Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res., 12, 1561–1572, 1995.
62. Shah, N.H., Carvajal, M.T., Patel, C.I., Infeld, M.H., Malick, A.W., Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm., 106, 15–23, 1994.
63. Pouton, C.W., Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification. Int. J. Pharm., 27, 335–348, 1985.
64. Wakerly, M.G., Pouton, C.W., Meakin, B.J., Evaluation of the self-emulsifying performance of a non-ionic surfactant-vegetable oil mixture. J. Pharm. Pharmacol., 39, 6, 1987.
65. Charman, S.A., Charman, W.N., Rogge, M.C., Wilson, T.D., Dutko, F.J., Pouton, C.W., Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm. Res., 9, 87–93, 1992.
66. Cherniakov, I., Domb, A.J., Hoffman, A., Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opin. Drug Deliv., 12, 1121–1133, 2015.
67. Soni, G.C., Prajapati, S.K., Chaudhri., N., Self Nanoemulsion, Advance Form of Drug Delivery System. WJPPS, 3, 410–436, 2014.
68. Rao, C.B., Vidyadhara, S., Sasidhar, R.L.C., Chowdary, Y.A., Design And Evaluation of Self-Nanoemulsified Drug Delivery System (SNEDDS) of Docetaxel by Optimizing the Particle Size using Response Surface Methodology. IAJPS, 1, 35–45, 2014.
69. Radha, G.V., Sastri, K.T., Burada, S., Rajkumar, J., A systematic review on self-micro emulsifying drug delivery systems: A potential strategy for drugs with poor oral bioavailability. Int. J. App. Pharm., 11, 23–33, 2019.
70. Shalaev, E., Wu, K., Shamblin, S., Krzyzaniak, J.F., Descamps, M., Crystalline mesophases: Structure, mobility, and pharmaceutical properties. Adv. Drug Deliv. Rev., 100, 194–211, 2016.
71. Pikal, M.J., Lukes, A.L., Lang, J.E., Gaines, K., Quantitative crystallinity determinations for beta-lactam antibiotics by solution calorimetry: correlations with stability. J. Pharm. Sci., 67, 767–773, 1978.
72. Lefort, R., Caron, V., Willart, J.F., Descamps, M., Mutarotational kinetics and glass transition of lactose. Solid State Commun., 140, 329–334, 2006.
73. Dujardin, N., Dudognon, E., Willart, J.F., Hédoux, A., Guinet, Y., Paccou, L. et al., Solid state mutarotation of glucose. J. Phys. Chem., 115, 1698–1705, 2011.
74. Mo, J., Milleret, G., Nagaraj, M., Liquid crystal nanoparticles for commercial drug delivery. Liq. Cryst. Rev., 5, 69–85, 2017.
75. Johari, G.P., Kim, S., Shanker, R.M., Dielectric study of equimolar acetaminophenaspirin, acetaminophen-quinidine, and benzoic acid-progesterone molecular alloys in the glass and ultraviscous states and their relevance to solubility and stability. J. Pharm. Sci., 99, 1358–1374, 2010.
76. Johari, G.P., Secondary relaxations and the properties of glasses and liquids, in: Molecular Dynamics and Relaxation Phenomena in Glasses, T. Dorfmüller and G. Williams (Eds.), pp. 90–112, Springer, Berlin Heidelberg, 1987.
77. Esposito, E., Cortesi, R., Drechsler, M., Paccamiccio, L., Mariani, P., Contado, C. et al., Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm. Res., 22, 2163–2173, 2005.
78. Li, J., Wu, L., Wu, W., Wang, B., Wang, Z., Xin, H. et al., A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate. Int. J. Pharm., 455, 75–84, 2013.
79. Lippacher, A., Müller, R., Mäder, K., Investigation on the viscoelastic properties of lipid based colloidal drug carriers. Int. J. Pharm., 196, 227–230, 2000.
80. Mehnert, W. and Mäder, K., Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev., 47, 165–196, 2001.
81. Shah, R., Eldridge, D., Palombo, E., Harding, I., Lipid Nanoparticles: Production, Characterization and Stability, Springer International Publishing, USA, 2015.
82. Battaglia, L., Trotta, M., Gallarate, M., Carlotti, M.E., Zara, G.P., Bargoni, A., Solid lipid nanoparticles formed by solvent-in-water emulsion–diffusion technique: development and influence on insulin stability. J. Microencapsul., 24, 672–684, 2007.
83. Svilenov, H. and Tzachev, C., Solid lipid nanoparticles–a promising drug delivery system, in: nanomedicines, A. Seifalian, A. de Mel, D.M. Kalaskar (Eds.), pp. 187–237, One Central Press Ltd, Manchester, 2014.
84. Schubert, M. and Müller-Goymann, C., Solvent injection as a new approach for manufacturing lipid nanoparticles–evaluation of the method and process parameters. Eur. J. Pharm. Biopharm., 55, 125–131, 2003.
85. Battaglia, L., Gallarate, M., Panciani, P.P., Sapino, S., Peira, E., Chirio, D., Techniques for the Preparation of Solid Lipid Nano and Microparticles, in: Application of Nanotechnology in DrugDelivery, A.D. Sezer (Ed.), pp. 51–75, IntechOpen Limited, London, 2014.
86. Charcosset, C., El-Harati, A., Fessi, H., Preparation of solid lipid nanoparticles using a membrane contactor. J. Control. Release, 108, 112–120, 2005.
87. Hou, D., Xie, C., Huang, K., Zhu, C., The production and characteristics of solid lipid nanoparticles (SLN). Biomaterials, 24, 1781–1785, 2003.
88. Liu, J., Gong, T., Wang, C., Zhong, Z., Zhang, Z., Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles. Preparation and characterization. Int. J. Pharm., 340, 153–162, 2007.
89. Li, Y., Taulier, N., Rauth, A.M., Wu, X.Y., Screening of lipid carriers and characterization of drug-polymer complex for the rational design of polymer-lipid hybrid nanoparticles. Pharm. Res., 23, 1877–1887, 2006.
90. Mehnert, W. and Mader, K., Solid lipid nanoparticles. Production, characterization and applications. Adv. Drug Deliv. Rev., 47, 165–196, 2001.
91. Pecora, R., Dynamic light scattering measurement of nanometer particles in liquids. J. Nanopart. Res., 2, 123–131, 2000.
92. Heurtault, B., Saulnier, P., Pech, B., Proust, J.E., Benoit, J.P., Physico-chemical stability of colloidal lipid particles. Biomaterials, 24, 4283–4300, 2003.
93. Zimmermann, E. and Muller, R.H., Electrolytes- and pH-stability of aqueous solid lipid nanoparticles (SLN) dispersion in artificial gastrointestinal media. Eur. J. Pharm. Biopharm., 52, 203–210, 2001.
94. Videira, M.A., Botelho, M.F., Santos, A.C., Gouveia, L.F., de Lima, J.J., Almeida, A.J., Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J. Drug Targeting, 8, 607–613, 2002.
95. Lin, P.C., Lin, S., Wang, P.C., Sridhar, R., Techniques
